Background: Leukocytes express Fcγ receptors, which are specific for the constant region of immunoglobulin G. Aggregation of these receptors activates a repertoire of responses that can lead to targeted cell killing by antibodydirected cellular cytotoxicity. The nature of the myeloid response to Fcγ receptor aggregation is highly variable and depends on the maturation state of the cell, but little is known about the signalling mechanisms underlying this variability.
Background
The Fcγ receptors of leukocytes are specific for the constant region (Fc) of immunoglobulin G (IgG) molecules and provide a pivotal link between the humoral and cellular arms of the immune system (see reviews [1] [2] [3] ). Antigen-antibody immune complexes aggregate Fcγ receptors and trigger a number of different effector functions in myeloid cells including endocytosis. Fcγ receptor aggregation activates a repertoire of responses including degranulation and release of proteases, activation of the respiratory burst and release of cytokines. Activation of these responses can ultimately lead to targeted cell killing by antibody-directed cellular cytotoxicity [4, 5] , which is critically important for clearing virus-infected cells and in cancer surveillance [6] . One feature of monocytes and macrophages harvested under different conditions and in different environments is the heterogeneity of their responses to immune complex challenge.
Three different classes of Fcγ receptors have been defined on the basis of their structures and affinities for IgG: FcγRI (CD64), FcγRII (CD32) and FcγRIII (CD16). Human FcγRI, a high-affinity IgG receptor, is an integral type I membrane glycoprotein [7] constitutively expressed on monocyte and macrophage cell types. The cytoplasmic tail of FcγRI contains no obvious signalling motif or homology with other immune system receptors. Aggregation of FcγRI, however, results in signal transduction, seen as protein tyrosine phosphorylation events [8] [9] [10] [11] and tyrosine kinase dependent calcium transients [12, 13] . In myeloid cells, FcγRI is associated non-covalently with the γ chain protein [14, 15] , which contains an immunoreceptor tyrosine activation motif (ITAM) necessary for activation of soluble tyrosine kinases [16] [17] [18] . The γ chain, a 7 kDa protein originally identified as a component of the high affinity IgE receptor (FcεRI) in mast cells [19] , is a member of a family of signal transducing molecules that includes the ζ chain of the T-cell receptor [20] . As a result of the non-covalent association between FcγRI and the γ chain, receptor aggregation results in clustering of the associated γ chain ITAMs and thereby triggers tyrosine kinase recruitment and activation [21] [22] [23] .
Activation of Fcγ receptors leads to the tyrosine phosphorylation of phospholipase Cγ1 [8] and resulting cytosolic calcium transients [10] . Little is known, however, about the signal transduction mechanisms underlying FcγRI signalling or how these mechanisms are modified as blood monocytes differentiate into tissue macrophages. Thus, to study early events in the FcγRI signalling pathway, we have used the human monocyte cell line U937 [24] , which constitutively expresses both FcγRI and the macrophagespecific low-affinity IgG receptor FcγRIIa, which contains an ITAM. U937 cells undergo controlled differentiation into a more macrophage cell type upon treatment with dibutyryl cAMP (dbcAMP) [25] and previous work has shown that the nature of the calcium response markedly changes as the cells become differentiated [12] . Thus, monocytic U937 cells, when primed with interferon-γ (IFN-γ), respond to Fcγ receptor aggregation with a single 'spike' of cytosolic calcium, whereas calcium oscillations are generated in response to Fcγ receptor aggregation in U937 cells differentiated to a more macrophage state by dbcAMP [26] . We now show that differentiation causes a fundamental and absolute developmental switch in the particular phospholipase pathway recruited following Fcγ receptor aggregation and that the calcium responses generated are consequent on this switch.
Results

Section 1: mobilisation of calcium undergoes a differentiation-dependent molecular switch
Differential generation of inositol phosphates following aggregation of Fcγ receptors
To examine the mechanism underlying the differentiation-dependent change in the calcium response of U937 cells, experiments were performed to define Fcγ receptor coupling to lipid signalling pathways that generate candidate messengers for eliciting calcium release. Thus, as it is well established that aggregation of Fcγ receptors leads to the recruitment of tyrosine kinases and the subsequent phosphorylation and presumed activation of phosphatidylinositol 4,5 bisphosphate phospholipase C (PtdInsP 2 -PLC) [8, 10, 11] , with the resultant generation of the calcium mobilising second messenger inositol-1,4,5-trisphosphate (InsP 3 ), our first approach was to investigate coupling to this pathway. Aggregation of Fcγ receptors did indeed have different effects on the activity of PtdInsP 2 -PLC in U937 cells treated with IFN-γ and dbcAMP. A small but significant transient rise in InsP 3 levels was observed following receptor aggregation in cells differentiated with dbcAMP ( Figure 1a ). By contrast, no increase in InsP 3 levels could be detected following receptor aggregation using the same stimulus in cells treated with IFN-γ ( Figure 1a ).
As the increase in measurable InsP 3 was small and transient even in cells differentiated with dbcAMP, we also measured the accumulation of total inositol phosphates in the presence of lithium chloride (10 mM), which prevents the breakdown of inositol phosphates [27, 28] , to ensure that any transient generation was not missed by sampling at specified time points. The results are shown in Figure 1b . In dbcAMP-differentiated cells, aggregation of Fcγ receptors initiated an increase in the levels of inositol phosphates that was detectable at the first time point tested (5 minutes) and steadily increased in a linear fashion thereafter. Surprisingly, the levels of inositol phosphates were not increased above control values in cells treated with IFN-γ even 20 minutes after receptor aggregation (Figure 1b) . Thus, the ability of activated Fcγ receptors to generate inositol phosphates depends on the differentiation state of U937 cells: InsP 3 is generated in dbcAMP-differentiated cells, but not in IFN-γ-treated 
Fcγ receptor is coupled to diacylglycerol production in both differentiation states
Our first clue to the potential calcium-mobilising signalling pathway used by Fcγ receptor in IFN-γ-treated cells was provided by experiments measuring mass diacylglycerol (DAG) generation. Unexpectedly, in contrast to the differences in levels of inositol phosphates, broadly similar levels of DAG were produced by Fcγ receptor aggregation in cells treated with IFN-γ or cells differentiated using dbcAMP ( Figure 2 ). As DAG can also be generated by activation of either phosphatidylcholine phospholipase C (PtdCho-PLC) or phosphatidylcholine phospholipase D (PtdCho-PLD) [28] (from phosphatidic acid (PtdOH) via phosphatidic acid phosphohydrolase), we next investigated whether either of these alternative pathways was responsible. To do this, DAG was measured in cells pretreated with butan-1-ol (0.3%), which traps PtdOH, the immediate product of PtdCho-PLD, in a non-hydrolysable form as phosphatidyl butanol (PtdBut) [28] . We controlled the specificity of this reaction using the stereoisoform butan-2-ol, which cannot act as an acceptor for the phosphatidyl moiety of PtdCho. In cells treated with IFN-γ, Fcγ-receptor-mediated DAG production was completely blocked by butan-1-ol whereas, in cells differentiated with dbcAMP, DAG production was completely unaffected ( Figure 2 ). Butan-2-ol had no effect on DAG production in either cell type (data not shown). These results suggest that in dbcAMP-differentiated cells DAG is, as expected from the observed levels of inositol phosphates, likely to be predominantly derived from PtdInsP 2 -PLC signalling. In contrast, in IFN-γ-treated cells DAG generation is entirely derived from coupling of Fcγ receptors to a PLD pathway. was demonstrated by pretreating cells with 0.3% butan-1-ol, which completely abolished the increase in sphingosine kinase activity observed after specific aggregation of FcγRI in IFN-γ-treated cells, whereas butan-2-ol had no effect on sphingosine kinase activation (data not shown). This clearly demonstrates that PtdCho-PLD activation is upstream of sphingosine kinase, a finding that is consistent with the previous observation that PtdOH can stimulate sphingosine kinase in vitro [32] .
Fcγ receptors are coupled to PLD in IFN-γ-treated cells but not in dbcAMP-differentiated cells
The role of components of the novel activation pathway (PtdCho-PLD and sphingosine kinase) identified in IFN-γ-primed cells in mediating the calcium transients was determined. Consistent with a role for sphingosine kinase, addition of the sphingosine kinase inhibitor D-Lthreo dihydro-sphingosine (DHS; 25µM) completely abolished the FcγRI-mediated calcium response in IFN-γ-treated but not dbcAMP-treated cells (data not shown). Furthermore, preincubation of IFN-γ-primed cells for 5 minutes with 0.3% butan-1-ol decreased the peak cytosolic calcium mobilisation from 217 ± 30 nM to 99 ± 29 nM.
Summary for section 1
Taking all this data together, we have shown that immune complexes trigger different phospholipid signalling pathways dependent on the differentiation state of the cell. In dbcAMP-differentiated cells, PtdInsP 2 -PLC is activated and calcium mobilised through the conventional pathway involving InsP 3 . In interferon-γ-primed cells, however, a novel pathway has been identified that involves sequential activation of PtdCho-PLD and sphingosine kinase and mobilisation of calcium through an InsP 3 -independent route. Moreover, the calcium transients were inhibited by both DHS and butanol, indicating that this pathway generates second messengers able to release calcium from stores using a novel mechanism.
Section 2: mechanism of the switch
The phospholipid signalling pathway used depends on which Fcγ receptor is aggregated
The switch in the phospholipid signalling pathway recruited by Fcγ receptor aggregation may result from the influence of differentiation on any one of the components of the pathway. To investigate whether the switch in phospholipase activation is defined by the nature of the predominant Fcγ receptor on the cell surface, monoclonal antibodies specific for either FcγRI or FcγRIIa were used to cross-link each receptor (see Materials and methods for more details). We compared the results of cross-linking the individual receptors with those obtained by immune complex activation in both IFN-γ-treated and dbcAMPdifferentiated cells.
In dbcAMP-differentiated cells, specific aggregation of either FcγRI or FcγRIIa gave similar results to those observed using human IgG, namely a measurable rise in the levels of inositol phosphates ( FcγRI is absolute and is identical to that observed for ligand (human IgG) activation (Figures 1-3) .
The FcγRI-dependent pathway in IFN-γ-treated cells is coupled to sphingosine kinase activation
As our studies had linked the activation of PtdCho-PLD with sphingosine kinase, the coupling of specific Fcγ receptors to sphingosine kinase and the effect of differentiation on its activation were examined using the monoclonal antibodies to aggregate each receptor specifically. Consistent with the identified switch in phospholipid signalling pathways, sphingosine kinase activity was stimulated only following the specific aggregation of FcγRI in IFN-γ-primed cells ( Figure 6 ). The sphingosine kinase activity did not rise above control values following aggregation of FcγRIIa in IFN-γ-treated cells or following aggregation of either FcγRI or FcγRIIa in dbcAMP-differentiated cells (Figure 6 ). Thus, the receptor specificity of sphingosine kinase activation exactly parallels that observed for activation of PtdCho-PLD (Figures 4e,5e ). These data therefore indicate that, in IFN-γ-treated cells, FcγRI is coupled to a pathway dependent on PtdCho-PLD and sphingosine kinase whereas, in dbcAMP-treated cells, FcγRI is coupled to PtdInsP 2 -PLC and production of InsP 3 . In contrast, FcγRIIa is coupled to the pathway dependent on PtdInsP 2 -PLC and InsP 3 in both cell types. [26] whereas in undifferentiated or IFN-γ-treated cells, the calcium response is in the form of a single spike. To determine whether the differential calcium responses observed following maturation reflect the change in the phospholipid signalling pathway recruited, we compared the nature of the calcium response resulting from aggregation of either FcγRI or FcγRIIa using monoclonal antibodies with the response triggered by cross-linking the ligand, human IgG.
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In dbcAMP-differentiated cells, about 50% of cells responded with calcium oscillations, regardless of the nature of the Fcγ receptor aggregated (Figure 7a-c,g ). In cells treated with IFN−γ, the nature of the aggregated receptor switched the nature of the calcium response ( Figure 7d-g) ; thus, specific aggregation of FcγRI resulted in a single spike of calcium (Figure 7e ), identical to that observed in response to human IgG (Figure 7d ), and specific cross-linking of FcγRIIa gave calcium oscillations in 50% of the cells, identical to those observed in dbcAMP-differentiated cells (Figure 7a-c,f,g ). Thus, the failure to observe calcium oscillations following ligand activation in IFN-γ-treated cells is not a feature of their lack of the appropriate cellular machinery as, given the relevant trigger (FcγRIIa cross-linking), these cells are able to establish calcium oscillations.
These data indicate that aggregation of FcγRIIa initiates calcium oscillations in U937 cells regardless of their differentiation status (Figure 7c,f,g ). The finding that specific aggregation of FcγRI in the two differentiation states gives different calcium responses completely matches the observed differentiation-dependent switch in phospholipid signalling pathways. Thus, the differentiationdependent switch in the activated phospholipid pathway dictates the nature of the calcium response.
Changes in FcγRIIa and γ chain expression upon IFN-γ and dbcAMP treatment are identical
Activation of both phospholipid pathways depended on the initial activation of tyrosine kinases: pretreatment of cells with the tyrosine kinase inhibitor genistein (0.37 mM) completely abolished the rise in PtdCho-PLD and sphingosine kinase activities following FcγRI aggregation in IFN-γ-treated cells (data not shown). To activate tyrosine kinases, FcγRI must recruit an accessory molecule as it contains no ITAM in its cytoplasmic tail. We therefore investigated whether IFN-γ and dbcAMP differentially induced expression of the γ chain and FcγRIIa, the two ITAM-bearing molecules able to interact with FcγRI.
Consistent with previous reports [7] , IFN-γ treatment resulted in a transient 15-fold increase of FcγRI mRNA levels (Figure 8a ). This transient rise in mRNA markedly precedes the increase in surface expression of FcγRI [7] . IFN-γ also increases both surface FcγRIIa [12] and the γ chain protein [14] in U937 cells. Consistent with these previous observations of protein expression, IFN-γ resulted in a transient increase of mRNA levels of both FcγRIIa and the γ chain (Figure 8a ). However, both these rises were much smaller (twofold over basal levels) than that observed for FcγRI mRNA, although the time course of the response for all three transcripts was identical.
Treatment of cells with dbcAMP resulted in a steady decrease in the amount of FcγRI mRNA such that after 48 hours levels had fallen to 50% of the starting level ( Figure 8b) ; however, as the protein on the cell surface appears to be stable, surface FcγRI remains readily detectable on these cells [12] . In contrast, levels of FcγRIIa mRNA rose steadily over time. These results of differential control of FcγRI and FcγRIIa expression are consistent with the known relative pattern of surface expression of the two receptors [12] . Surprisingly, γ chain mRNA levels also rose during treatment of the cells with dbcAMP in an identical manner to that observed for FcγRIIa (Figure 8b) . Thus, the mRNAs encoding both ITAM-containing molecules behave in an identical fashion following cytokine treatment and differentiation. Regulation of the molecular switch in FcγRI signal transduction must therefore be more complex than a mere change in the relative stoichiometry of FcγRI to either of its accessory molecules.
Mechanism of the molecular switch in FcγRI-mediated signalling following differentiation
The role of the two accessory molecules (FcγRIIa and the γ chain) in signal transduction by FcγRI was next investigated by blocking the induction of their expression using antisense oligonucleotides. In IFN-γ-treated cells, loading cells with antisense γ chain completely abolished the increase in PtdCho-PLD activity observed following specific aggregation of FcγRI with monoclonal antibodies (Figure 9a ). Loading cells with an equivalent antisense oligonucleotide to FcγRIIa had no influence at all on FcγRI-stimulated activation of PtdCho-PLD (Figure 9a) . In IFN-γ-treated cells, we have shown that specific aggregation of FcγRIIa activates PtdInsP 2 -PLC with generation of inositol phosphates (Figure 5a) . Therefore, to check the specificity of these antisense oligonucleotides, their ability to interfere with FcγRIIa-mediated activation of PtdInsP 2 -PLC was investigated. The normal increase in inositol phosphates observed after specific aggregation of FcγRIIa was blocked in cells loaded with the oligonucleotide antisense to FcγRIIa (Figure 9b ). The oligonucleotide antisense to the γ chain had no influence on the ability of FcγRIIa to activate PtdInsP 2 -PLC (Figure 9b ). These data, therefore, definitively demonstrate that FcγRI is coupled to PtdCho-PLD activation through the γ chain in IFN-γ-treated cells and that FcγRIIa plays no role in signal transduction for the high-affinity receptor in these cytokine-primed cells.
In cells differentiated to macrophage type using dbcAMP, FcγRI switches the nature of the activated intracellular signalling pathway by switching the accessory molecule used for signal transduction. Thus, loading differentiated cells with antisense FcγRIIa completely abolished the accumulation of inositol phosphates observed after aggregation of either FcγRIIa or FcγRI (Figure 9c) . In contrast to the results in IFN-γ-treated cells, loading these differentiated cells with antisense γ chain had no effect on FcγRI-mediated signalling (Figure 9c ). These data therefore, definitively demonstrate that following differentiation FcγRI recruits FcγRIIa for signal transduction.
The antisense oligonucleotides act as reciprocal internal controls for each other as neither antisense oligonucleotide influenced the receptor activation of the alternative pathway (Figure 9a-c) . Moreover, surface expression of total immunoreactive FcγRII was reduced by some 30% in cells treated with the oligonucleotide antisense to FcγRIIa (data not shown). As monoclonal antibodies to FcγRII are unable to distinguish between the six potential isoforms of FcγRII, this observation probably represents a considerable underestimate of the specific effect of the antisense oligonucleotide on the expression of FcγRIIa, the only ITAM-bearing form of FcγRII. Finally, for both pathways, a standard 'jumbled' antisense control oligonucleotide was also assessed for nonspecific effects. Loading cells with this oligonucleotide did not influence the activation of either pathway (Figure 9d,e) . Taken together, these data clearly demonstrate that the differentiation-dependent switch in signalling pathways recruited by aggregated FcγRI results from a change in its recruitment of accessory molecules.
Summary for section 2
The notable findings from this study are, firstly, that the two Fcγ receptors (FcγRI and FcγRIIa) initiate fundamentally different phospholipid signalling pathways in IFN-γ-treated cells. Both pathways are present, intact and functional in IFN-γ-treated cells but the two Fcγ receptors are differentially and exclusively coupled. The second finding is that the phospholipid pathway activated by specific cross-linking of FcγRI in monocytic and macrophagelike cells exactly mimics the differentiation-dependent switch in intracellular signalling observed for immune complex activation and results from a switch in the ability of this receptor to recruit different ITAM-bearing accessory molecules following differentiation. 
Discussion
We have shown that there is a fundamental and absolute switch in the nature of the intracellular signalling pathway activated by immune complexes when a monocytic cell line differentiates to a more macrophage-like cell. Thus, in cells primed with IFN-γ, the release of intracellular calcium from stores is InsP 3 independent and is mediated by the sequential activation of PtdCho-PLD and sphingosine kinase. This newly identified signalling pathway presumably involves a sphingoid base acting on the recently cloned SCaMPER receptor [34] in the endoplasmic reticulum to effect the release of calcium from stores [29] . In dbcAMP-differentiated cells, the same immune complex challenge resulted in the activation of only PtdInsP 2 -PLC; activation of the pathway involving PtdCho-PLD and sphingosine kinase could not be detected.
The ability of FcγRI to switch signalling pathways reflects the fact that, unlike FcγRIIa, the cytoplasmic tail of FcγRI contains no known signalling or ITAM motif but must recruit one of two accessory molecules. Therefore, unlike FcγRIIa, which through its intrinsic ITAM [33] demonstrates obligate coupling to PtdInsP 2 -PLC, FcγRI is able to switch recruitment between the γ chain and FcγRIIa in a differentiation-dependent fashion and thereby couple to different intracellular signalling pathways. In dbcAMPdifferentiated cells, FcγRI recruits FcγRIIa whereas, in cytokine primed cells, FcγRI uses the γ chain. The control of this switch does not rely on regulation of levels of the γ chain but rather appears to depend on the relative levels of FcγRI and FcγRIIa. The activation of different signalling pathways probably accounts for the different responses of myeloid cells to challenge with immune complexes. As many immune receptors have separate polypeptide chains for ligand binding and signal transduction (allowing a similar switch in signalling pathways) the mechanism defined here is likely to be widely used.
Implications for myeloid function of the differential signalling by Fcg receptors
The finding that differentiation to a more macrophage cell type causes U937 cells to switch the signalling pathways activated by Fcγ receptors such that prolonged calcium signals are generated agrees with our previous finding that dbcAMP upregulates capacitative calcium entry [35, 36] , which is required for refilling of the calcium stores. It is tempting to speculate that the differentiation process primes cells to produce a prolonged response to immune complex activation by switching the nature of the second messenger to InsP 3 and inducing capacitative calcium entry to allow store filling, thereby maintaining the calcium signal. Another likely immediate consequence of this switch in phospholipase activation and calcium signalling is the differential activation of protein kinase C isoforms, which are involved in a number of myeloid functions such as phagocytosis and endocytosis [37] . Such differential protein kinase C signalling may explain the finding that FcγRI-triggered phagocytosis is calcium independent whereas FcγRII-mediated phagocytosis can be inhibited by buffering cytoplasmic calcium [38] . Thus, this fundamental and absolute molecular switch in the activation of phospholipid signalling pathways following differentiation of cells to a macrophage cell phenotype provides a method of precisely controlling the nature of the cellular response to immune complexes.
Materials and methods
Materials and cell culture
U937 cells were cultured in RPMI1640 (Gibco) supplemented with foetal calf serum (10%), glutamine (2 mM, penicillin (10 U/ml) and streptomycin (10 µg/ml) at 37°C, 6.8% carbon dioxide in a water saturated atmosphere. The cells were treated with IFN-γ (Bender Wein Ltd; 200 ng/ml) for 24 h or dbcAMP (1 mM) for 48 h. Antisense oligonucleotides were purchased from Oswell DNA Services; 24-mers were synthesised, capped at either end by the phosphothiorate linkages (first two and last two linkages), and corresponded to the reverse complement of the first 8 amino acids for either the γ chain or FcγRIIa. The sequences of the oligonucleotides were 5′-GAGCAAGACCACTGC-TGGAATCAT-3′ for the γ chain, 5′-TCTGGGACATACATTCTGAGA-CAT-3′ for FcγRIIa, and the jumbled control 5′-CTGGTGGA-AGAAGAGGACGTCCAT-3′. Cells were incubated in 10 µM oligonucleotide for 1 hour prior to, and then for the duration of, culture with either IFN-γ or dbcAMP.
Receptor aggregation for the biochemical assays
Cells were harvested by centrifugation (200 g). For experiments using ligand to aggregate the receptors, cells were incubated for 30 min on ice with 1 µM human monomeric, polyclonal IgG (Serotec) to occupy the surface FcγRI. Excess unbound ligand was removed by dilution and centrifugation of the cells. Cells were resuspended and ligand-occupied receptors were then aggregated by addition of 1:100 dilution of F(ab) goat anti-human IgG (Sigma) on ice ( Figure 10 ). Cells were then warmed to 37°C for the times specified in the assays. To aggregate specific Fcγ receptors, cells were incubated with specific monoclonal antibodies for 30 min on ice ( Figure 10 ). To aggregate FcγRI, cells were incubated with 1 µg of the monoclonal antibodies 22 and 32 which recognise separate epitopes on FcγRI away from the binding pocket. To aggregate FcγRIIa specifically, cells were incubated with the monoclonal antibody 2e1 (Serotec) in the presence of 3 µM human IgG4 (Serotec) to occupy the ligand-binding pocket of FcγRI. After removal of excess antibody by dilution and centrifugation, the receptors were cross-linked by the addition of F(ab) goat anti-mouse IgG F(ab) (1:50 dilution; Sigma). Cells were then warmed to 37°C for the times specified in the assays.
Measurement of inositol phosphates, DAG, PLD activity and sphingosine kinase activity
Inositol phosphates were assayed essentially as described in Harnett and Harnett [39] , mass DAG was measured as described in Briscoe et al. [27] , PLD activity was measured by the transphosphatidylation assay [27, 28] and sphingosine kinase was assayed as described in Olivera et al. [40] . More details of these methods are available as Supplementary material (published with this paper on the internet).
Single cell measurement of changes in cytosolic calcium
U937 cells treated with dbcAMP (1 mM) or IFN-γ (200 ng/ml) were harvested and cells resuspended in HEPES-buffered saline (HBS) supplemented with 1 mM CaCl 2 . Cells were incubated simultaneously with primary antibody (either human human IgG (1 µM) or the FcγRI-specific monoclonal antibody 32 or FcγRIIa-specific monoclonal antibody 2e1 plus 1 µM human IgG4) and 5 µM Fluo3-AM (Molecular Probes) mixed with an equal volume of 25% w/v Pluronic F127 at room temperature for 30 min. After centrifugation, cells were resuspended in HBS containing 1 mM Ca 2+ at room temperature and aliquots were settled on poly-L-lysine coated coverslips and placed in a perfusion chamber heated to 37°C. The perfusion bath was thoroughly perfused with HBS containing 2 mM Ca 2+ to remove excess antibody and ensure complete solution change. For cells loaded with human IgG, receptors were then aggregated by addition of F(ab) fraction of goat anti-human IgG F(ab) antibody (1:50 dilution). For cells loaded with the FcγR-specific monoclonal antibodies, receptors were cross-linked with a F(ab) preparation of a goat antibody specific for mouse IgG F(ab). Scanning confocal imaging was achieved using a Zeiss inverted confocal microscope. Excitation light (488 nm) was provided by an argon laser and emitted light was detected at wavelengths above 515 nm. Laser attenuation, pinhole size and photomultiplier brightness/contrast settings were maintained constant for all experiments. Frames were acquired every 3 sec (512 × 512 pixels) and pixels assigned intensity values (0-255). Transmitted visible light images were routinely taken before and after every experiment to exclude artefactual changes in fluorescence caused by movement of cells in the focal plane. Results were adjusted for dye photobleach assessed in unstimulated cells. Data analysis were carried out using Metamorph and Sigmaplot (Jandel Scientific Corp) software. Oscillations were defined as responses with two or more peaks separated by more than one data point.
Measurement of calcium concentrations in cell populations
To measure the release of calcium from intracellular stores, experiments were performed on cell populations in nominally Ca 2+ free HBS (at 37°C) using a Cairn Research Spectrophotometer and cells loaded with fura-2 (Molecular Probes) as described previously [12, 41] .
Northern blot analysis
Cells were treated with IFN-γ or dbcAMP and harvested at set times. Messenger RNA for FcγRI, FcγRIIa and γ chain were probed by northern blot analysis using cDNAs for each as described previously [7, 19, 33] .
Supplementary material available
Details of some of the methods used are published with this paper on the internet. 
